ReviewFrontiers in oncology2014

Drug resistance to molecular targeted therapy and its consequences for treatment decisions in non-small-cell lung cancer.

Johanna N Spaans et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.